Researchers review the primary clinical and research questions regarding blood pressure (BP) reduction with vasodilators in the early management of hypertensive acute heart failure (H-AHF).
Dapagliflozin may reduce the risk for hospitalization for heart failure and adverse renal outcomes regardless of baseline characteristics in patients with type 2 diabetes and multiple risk factors.
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
Patients with mild heart failure whose disease stabilizes with cardiac resynchronization therapy (CRT) experience a longer survival that is similar to that observed in patients whose HF improves with CRT.
Researchers examined the association between serum potassium concentration and outcomes in patients with heart failure with preserved ejection fraction.
